International Conference on Cancer Biology and Targeted Therapies (ICCBTT - 26)

This track focuses on the latest developments in cancer genomics, including the identification of oncogenes and tumor suppressor genes. Participants will explore how genomic data can inform targeted therapies and precision medicine approaches.

This session will delve into the molecular pathways that drive cancer development, including signaling pathways and their roles in cell proliferation and apoptosis. Understanding these mechanisms is crucial for developing effective therapeutic strategies.

This track examines the interactions between tumor cells and their microenvironment, highlighting how these relationships influence cancer progression and metastasis. Insights gained here are vital for designing novel therapeutic interventions.

This session will explore the discovery and validation of cancer biomarkers that can aid in early diagnosis and treatment monitoring. The focus will be on how these biomarkers can enhance personalized oncology.

This track will highlight recent innovations in targeted therapies, including the development of new drugs that specifically target molecular pathways involved in cancer. Discussions will include case studies and clinical trial outcomes.

This session will investigate the various mechanisms by which cancer cells develop resistance to chemotherapeutics. Understanding these mechanisms is essential for improving treatment efficacy and patient outcomes.

This track focuses on the implementation of precision medicine in oncology, emphasizing individualized treatment plans based on genetic, environmental, and lifestyle factors. Participants will discuss challenges and successes in tailoring therapies to specific patient profiles.

This session will cover emerging therapeutic strategies, including immunotherapy and combination therapies, that aim to enhance treatment effectiveness. The discussions will focus on innovative approaches to overcome current limitations in cancer care.

This track will explore the cellular and molecular mechanisms underlying cancer metastasis, including the role of the tumor microenvironment. Understanding these processes is critical for developing strategies to prevent and treat metastatic disease.

This session will provide an overview of the latest research on oncogenes and tumor suppressor genes, focusing on their roles in cancer biology. Participants will discuss how these insights can inform targeted therapeutic approaches.

This track will look ahead to future directions in cancer research, including novel technologies and methodologies that could revolutionize our understanding of cancer biology. Emphasis will be placed on interdisciplinary approaches and collaborative efforts in the field.